Mentioned Users

MyBCTeam

That sounds like a fascinating area of research! However, that topic falls outside the scope of what can be helpfully addressed here, as the focus is specifically on breast cancer.

If you have HER2-positive breast cancer, there are actually some exciting newer treatment developments worth knowing about. Here's a quick Show Full Answer

That sounds like a fascinating area of research! However, that topic falls outside the scope of what can be helpfully addressed here, as the focus is specifically on breast cancer.

If you have HER2-positive breast cancer, there are actually some exciting newer treatment developments worth knowing about. Here's a quick overview of the main targeted therapy categories:

- Monoclonal antibodies – Lab-made proteins that attach to HER2 to stop cancer cells from growing (e.g., Herceptin, Perjeta, Phesgo)
- Tyrosine kinase inhibitors (TKIs) – Pill-form treatments that block signals telling cancer cells to grow (e.g., Tukysa, Tykerb, Nerlynx)
- Antibody-drug conjugates (ADCs) – A combo of targeted therapy and chemo that delivers treatment directly to cancer cells (e.g., Enhertu, Kadcyla)
- CDK4/6 inhibitors – Newer additions that block proteins helping cancer cells divide (e.g., Ibrance)

Research in this space is growing rapidly, with hundreds of clinical trials currently underway. Talking with your oncologist about what's newest and most relevant to your specific situation is always the best next step.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

HER2-Positive Breast Cancer: Prognosis and Survival Rates